Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.2310
-0.0330 (-12.50%)
May 21, 2026, 11:58 AM CET
Market Cap16.99M -28.3%
Revenue (ttm)n/a
Net Income-6.93M
EPS-0.12
Shares Out64.36M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume707,918
Average Volume8,298,146
Open0.2620
Previous Close0.2640
Day's Range0.2010 - 0.2620
52-Week Range0.0274 - 0.6460
Beta-0.88
RSI61.10
Earnings DateMay 28, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements